« Back to the previous page

Also available in:

Buyer for biologics CDMO in Europe

Company to buy

  • Size: large
  • Revenue: 10-100 million EUR
  • Location of the target company: Southern Europe 
  • Reason for acquisition: The company wants a biologics CDMO in Europe to expand the company’s operations
  • #CFIE PHB131

Overview of this Buyer for biologics CDMO in Europe

This buyer is a pharmaceutical company focused on manufacturing molecule APIs, dosage forms and biologics. The company is interested in acquiring a CDMO company to expand the company’s operations in Europe.

Profile (strategy) of this Buyer for biologics CDMO in Europe

The buyer is a company founded in earlier 2000’s decade offering solutions on small molecule API and intermediate CDMO services, drug product and biologics CDMO services. The company provides services since the R&D process to manufacturing. 

The company operates 3 Process R&D Centers, 2 Process Technology Centers, 2 Manufacturing Facilities and offices around the world. Each manufacturing plant and R&D center is responsible for a different specialization. All the facilities are GMP certified, follow ISO standards and are USFDA/EMA/PDMA inspected.

The company exports worldwide and have operations across the world counting with more than 2,500 employees and more than 200 million EUR in revenue with a 18% CAGR. 

Sell your biologics CDMO in Europe

Contact us to get details about this buyer for biologics CDMO in Europe

Activities and products of the target 

The buyer is looking for a biologics CDMO in Europe. An interesting company to this buyer would be a CDMO company with intermediates and API activities, with good margins and profitable. 

Highlights of this Buyer for biologics CDMO in Europe

  • API and CDMO biologics services
  • Facilities around the world 
  • Stock listed company

Information about this Buyer for biologics CDMO in Europe

Feel free to contact us for more information regarding this Buyer for biologics CDMO in Europe or if you know possible interested or suitable parties. For more Buyer for biologics CDMO in Europe, please visit the section pharmaceutical companies wanted. For pharmaceutical firms for sale visit the section pharmaceutical companies for sale

Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.